← FDA Drug Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2014-08-27

Drug application

FDA Application #

ANDA202526

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLOPATADINE HYDROCHLORIDE

Generic name

Olopatadine Hydrochloride

Active ingredients

OLOPATADINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

OPHTHALMIC

Marketing status

None (Tentative Approval)

Sponsor

WATSON LABS INC

First approval

2014-08-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown